International Journal of Molecular Sciences · 2015 · 53 citations · 18 references
Life SciencesBiochemistryNeuroscienceMolecular NeuroscienceNeurochemistryNeuropharmacologyAlzheimer DiseaseAmyloid FormationAntioxidant DefenseNeurodegenerative DiseasesNeurodegenerative DisordersNeuroprotectionAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid FibrilsAmyloid-beta-induced NeurotoxicityChitosan OligosaccharidesCircular DichroismNeuroprotective MechanismsProtein Aggregation Inhibition
Alzheimer's disease (AD) is characterized by a large number of amyloid-β (Aβ) deposits in the brain. Therefore, inhibiting Aβ aggregation or destabilizing preformed aggregates could be a promising therapeutic target for halting/slowing the progression of AD. Chitosan oligosaccharides (COS) have previously been reported to exhibit antioxidant and neuroprotective effects. Recent study shows that COS could markedly decrease oligomeric Aβ-induced neurotoxicity and oxidative stress in rat hippocampal neurons. However, the potential mechanism that COS reduce Aβ-mediated neurotoxicity remains unclear. In the present study, our findings from circular dichroism spectroscopy, transmission electron microscope and thioflavin T fluorescence assay suggested that COS act as an inhibitor of Aβ aggregation and this effect shows dose-dependency. Moreover, data from thioflavin T assay indicated that COS could significantly inhibit fibrils formation and disrupt preformed fibrils in a dose-dependent manner. Furthermore, the addition of COS attenuated Aβ1-42-induced neurotoxicity in rat cortical neurons. Taken together, our results demonstrated for the first time that COS could inhibit Aβ1-42 fibrils formation and disaggregate preformed fibrils, suggesting that COS may have anti-Aβ fibrillogenesis and fibril-destabilizing properties. These findings highlight the potential role of COS as novel therapeutic agents for the prevention and treatment of AD.
18
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text
Preventing Alzheimer’s Disease
Dennis J. Selkoe · Science · 2012 · 376 citations · Full text